Mon, Dec 29, 2014, 4:02 AM EST - U.S. Markets open in 5 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • pharmaherocc pharmaherocc Feb 1, 2012 8:05 AM Flag

    (DSCO) FDA DECISION 6 MARCH=5 BAGGER (Mcap 53 M) !!!

    TIME TO LOAD UP THE VERY CHEAP SHARES OF THIS ALMOST UNKNOW LOW FLOAT MONSTER .MARKET CAP OF 53 M IS A BIG JOKE .GLTA

    Surfaxin has $ 500 M market potential once approved it will push DSCO into Double Digits easily .

    DSCO is significantly at current levels .FDA runup could start any time now which will drive this LOW FLOAT MONSTER to 4-5 Dollars .

    GREAT BUYING OPPORTUNITY HERE ....


    Discovery Labs (DSCO)

    Market Cap : $ 53 M
    Cash : $ 15.4 M
    Price : 2.18

    Shares Out : 24 .5 M


    Discovery Laboratories (DSCO) – Decision Date: March 6, 2012

    Drug: Surfaxin – Treatment: prevention of respiratory distress syndrome in premature infants.

    Discovery Labs also has a few drugs in its pipeline. Aerosurf is in Phase 2 for the treatment of moderate respiratory distress syndrome. Liquid KL4 Surfactant is in Phase 2 to treat a wide range of respiratory diseases. Aerosolized KL4 Surfactant is in early development to treat acute lung injury and bronchiectasis. The same drug is in Phase 2 for treating cystic fibrosis.




















    23r23rdr32d32d32dr32r

 
NBIX
22.77+1.44(+6.75%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Harley-Davidson, Inc.
NYSEFri, Dec 26, 2014 4:03 PM EST
Sasol Ltd.
NYSEFri, Dec 26, 2014 4:02 PM EST
ARMOUR Residential REIT, Inc.
NYSEFri, Dec 26, 2014 4:01 PM EST